When you buy through link on our site , we may garner an affiliate military commission . Here ’s how it works .

The Food and Drug Administration ( FDA ) recently approved a new drug to treatlow sex drive in woman .

But how exactly does the drug work , and what makes it unlike from the other medicine on the market ?

Article image

The drug , shout bremelanotide ( brand name Vyleesi ) has been approved to treat premenopausal women with underactive intimate desire disorderliness ( HSDD ) , a shape in which low sexual desire make personal distress , the FDAsaid in a program line . It is only the second FDA - okay drug for HSDD in woman .

woman self - mete out the shot under the pelt of the abdomen or second joint at least 45 arcminute before anticipated sexual activity . Women should not take more than one dose of bremelanotide within a 24 - hour stop or more than eight doses per month . [ 5 Myths About Women ’s Bodies ]

In a study of more than 1,200 premenopausal women with HSDD , 25 % of those who took bremelanotide saw some improvements in their report intimate desire scores , compared with 17 % who took a placebo .

a rendering of an estrogen molecule

Bremelanotide binds to receptor in the brain called melanocortin receptors , whichplay a role in many biological functions , such as metabolism and food for thought inspiration , skin pigmentation and pain regulation . But it ’s unclear exactly how the drug run to supercharge sexual desire , the FDA said .

However , the main theory is that bremelanotide works by increasingdopamine — a brain chemical involved in reward processing — in sealed parts of the brain , said Sheryl Kingsberg , chief of the Division of Behavioral Medicine at University Hospitals Cleveland Medical Center , who has learn bremelanotide . This , in turn , allows cleaning woman to " treat erotic input as rewarding , " said Kingsberg , who has take in consulting payments from AMAG Pharmaceuticals , which markets Vyleesi , and Palatin Technologies , which developed the drug .

Kingsberg told Live Science that it ’s speculate that normal intimate single-valued function bank on a Libra of excitatory and inhibitory signals in the brain , and HSDD is the result of either not enough excitation or too much prohibition . Within this line of thinking , bremelanotide is hypothesized to promote the excitation response by releasing Intropin , she enounce .

a group class of older women exercising

The only other FDA - sanction drug for HSDD isflibanserin(brand name Addyi ) . Flibanserin acts on a different brain receptor , and it partially blocks the production of the brain chemical serotonin , Kingsberg said . Serotonin is think to muffle sexual practice drive in part by inhibiting the excitatory dopamine system , according to a 2017 review inThe Journal of Sexual Medicine .

The two drugs also differ in their dose frequence — flibanserin call for to be take every mean solar day at bedtime , while bremelanotide is taken as needed . drug used to handle male intimate dysfunction , such as sildenafil ( brand name name Viagra ) , mainly target an enzyme called phosphodiesterase 5 ( PDE5 ) , which plays a function in influence blood flow to the phallus . By blockade the enzyme , sildenafil ’s overall issue is to increase descent flow to the penis , which leads to an erection . However , sildenafil does not boost sex drive .

The most vernacular side result of flibanserin are sleepiness and lightheadedness , while the most common side effect of bremelanotide is sickness , Kingsberg say .

an edited photo of a white lab mouse against a pink and blue gradient background

In studies of bremelanotide , 40 % of women experienced nausea , most commonly with their first injection of the drug , and 13 % needed to take treatments for their sickness , the FDA read . Still , more than 90 % of women who experienced nausea stayed in the drug trial , suggesting that either their nausea was soft or they feel that the benefit of the drug overbalance the side effect , Kingsberg order .

Bremelanotide should n’t be used in people with uncontrolledhigh blood pressureor those with heart disease , the FDA says . In addition , patient should quit taking bremelanotide after eight weeks if they do n’t see an improvement in their sexual desire and related to distress .

Originally print onLive skill .

a person holds a GLP-1 injector

a photo of burgers and fries next to vegetables

a point-of-view image of an anaesthetist placing a mask on a patient

Scientist

A CT scan of a woman�s head shows an arrow pointing to a large hole in her septum

marijuana

An abstract illustration of a euphoric state.

Nobel Assembly member, Randall Johnson, speaks during the announcement of this year’s winners of the Nobel Prize in Physiology or Medicine, at the Karolinska Institute in Sweden: (from left to right on the screen) Gregg Semenza, Peter Ratcliffe and William Kaelin.

Containers of the drug Zantac.

An image comparing the relative sizes of our solar system�s known dwarf planets, including the newly discovered 2017 OF201

an illustration showing a large disk of material around a star

A man with light skin and dark hair and beard leans back in a wooden boat, rowing with oars into the sea

an MRI scan of a brain

A photograph of two of Colossal�s genetically engineered wolves as pups.

Pelican eel (Eurypharynx) head.